💊 Pharmaceuticals · Wilmington, Delaware
Merck: Wilmington biologics center
💰 $1 billion👷 500 jobs (more than, plus about 4,000 construction jobs)🏗️ Under construction since April 2025; labs in 2028, production by 2030A 470,000 square foot biologics plant at Chestnut Run, planned as the future U.S. home of Keytruda production.
How to get on the sub list
The general contractor hasn't been announced publicly; watch local news and county permits. Merck: what we buy →
Source: Contract Pharma, Apr 2025 · checked Oct 25, 2026
💊 Pharmaceuticals · Newark, Delaware
Wilmington PharmaTech: API manufacturing expansion
💰 $50 million🏗️ Announced March 23, 2026; new suites expected online in Q3 2027Two new 10,000-liter reactor suites that more than double the campus's drug-ingredient capacity and roughly double its workforce.
How to get on the sub list
The general contractor hasn't been announced publicly; watch local news and county permits.
Source: Business Wire · checked Oct 26, 2026
Government bids in Delaware, too
Cities, counties and state agencies post new work every week.
Investment and job figures are the companies' own announced numbers, from the source on each card. Contrax isn't affiliated with these companies.